Literature DB >> 3470799

Evidence for sequential expression of multiple AMP deaminase isoforms during skeletal muscle development.

R Marquetant, N M Desai, R L Sabina, E W Holmes.   

Abstract

AMP deaminase (myoadenylate deaminase; EC 3.5.4.6) is an integral part of the myofibril in skeletal muscle, and this enzyme plays an important role in energy metabolism in this tissue. We report here the identification of three AMP deaminase isoforms during skeletal muscle development in the rat. An embryonic isoform is expressed in the developing hindlimb of the rat between 7 and 14 days of gestation. This isoform is not unique to skeletal muscle or the embryo as it is also expressed in many nonmuscle tissues of the perinatal and adult rat. A perinatal isoform of AMP deaminase that is restricted to skeletal muscle is produced 4-6 days before birth and persists for 2-3 weeks of postnatal life. An adult, skeletal muscle-specific isoform of AMP deaminase appears at birth and reaches maximal levels after 3 weeks of postnatal development. We conclude from these studies there is a developmentally controlled program that leads to the sequential expression of AMP deaminase isoforms during the transition from embryonic to adult skeletal muscle.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3470799      PMCID: PMC304647          DOI: 10.1073/pnas.84.8.2345

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  51 in total

1.  Isozymes of AMP deaminase in red and white skeletal muscles.

Authors:  A Raggi; C Bergamini; G Ronca
Journal:  FEBS Lett       Date:  1975-10-15       Impact factor: 4.124

2.  Isozymes of rat AMP deaminase.

Authors:  N Ogasawara; H Goto; T Watanabe
Journal:  Biochim Biophys Acta       Date:  1975-10-22

3.  High resolution two-dimensional electrophoresis of proteins.

Authors:  P H O'Farrell
Journal:  J Biol Chem       Date:  1975-05-25       Impact factor: 5.157

4.  AMP deaminase from rat brain: purification and characterization of multiple forms.

Authors:  N Ogasawara; H Goto; T Watanabe; Y Kawamura; M Yoshino
Journal:  Biochim Biophys Acta       Date:  1974-10-17

5.  Multiple forms of AMP deaminase in various rat tissues.

Authors:  N Ogasawara; H Goto; T Watanabe; Y Kawamura; M Yoshino
Journal:  FEBS Lett       Date:  1974-08-15       Impact factor: 4.124

6.  Multiple forms of AMP deaminase in rat brain.

Authors:  N Ogasawara; M Yoshino; Y Kawamura
Journal:  Biochim Biophys Acta       Date:  1972-02-28

7.  Cleavage of structural proteins during the assembly of the head of bacteriophage T4.

Authors:  U K Laemmli
Journal:  Nature       Date:  1970-08-15       Impact factor: 49.962

8.  AMP-aminohydrolase of human skeletal muscle: partial purification and properties.

Authors:  W Makarewicz; A Stankiewicz
Journal:  Biochem Med       Date:  1974-06

9.  An improved purification, crystallization, and some properties of rabbit muscle 5'-adenylic acid deaminase.

Authors:  K L Smiley; A J Berry; C H Suelter
Journal:  J Biol Chem       Date:  1967-05-25       Impact factor: 5.157

10.  Rat muscle 5'-adenylic acid aminohydrolase. I. Purification and subunit structure.

Authors:  C J Coffee; W A Kofke
Journal:  J Biol Chem       Date:  1975-09-10       Impact factor: 5.157

View more
  13 in total

1.  AMP-deaminase from human term placenta.

Authors:  A Swieca; I Rybakowska; G Nagel-Starczynowska; E Kossowska; K Kaletha
Journal:  Mol Cell Biochem       Date:  2003-10       Impact factor: 3.396

2.  Full-size form of human liver AMP-deaminase?

Authors:  M Szydlowska; Z Chodorowski; I Rybakowska; G Nagel-Starczynowska; K Kaletha
Journal:  Mol Cell Biochem       Date:  2004-11       Impact factor: 3.396

3.  Expression of three stage-specific transcripts of AMP deaminase during myogenesis.

Authors:  R L Sabina; N Ogasawara; E W Holmes
Journal:  Mol Cell Biol       Date:  1989-05       Impact factor: 4.272

4.  Developmental forms of human skeletal-muscle AMP deaminase. The kinetic and regulatory properties of the enzyme.

Authors:  K Kaletha; G Nowak
Journal:  Biochem J       Date:  1988-01-01       Impact factor: 3.857

5.  Regulation of rat AMP deaminase 3 (isoform C) by development and skeletal muscle fibre type.

Authors:  D K Mahnke-Zizelman; J D'cunha; J M Wojnar; M A Brogley; R L Sabina
Journal:  Biochem J       Date:  1997-09-01       Impact factor: 3.857

6.  A novel pathway for alternative splicing: identification of an RNA intermediate that generates an alternative 5' splice donor site not present in the primary transcript of AMPD1.

Authors:  I Mineo; P R Clarke; R L Sabina; E W Holmes
Journal:  Mol Cell Biol       Date:  1990-10       Impact factor: 4.272

7.  Molecular basis of AMP deaminase deficiency in skeletal muscle.

Authors:  T Morisaki; M Gross; H Morisaki; D Pongratz; N Zöllner; E W Holmes
Journal:  Proc Natl Acad Sci U S A       Date:  1992-07-15       Impact factor: 11.205

Review 8.  Molecular biology of AMP deaminase deficiency.

Authors:  M Gross
Journal:  Pharm World Sci       Date:  1994-04-15

9.  The phenotype of lymphoid cells and thymic epithelium correlates with development of autoimmune insulitis in NOD in equilibrium with C57BL/6 allophenic chimeras.

Authors:  S Forsgren; U Dahl; A Söderström; D Holmberg; T Matsunaga
Journal:  Proc Natl Acad Sci U S A       Date:  1991-10-15       Impact factor: 11.205

10.  Functionally distinct elements are required for expression of the AMPD1 gene in myocytes.

Authors:  T Morisaki; E W Holmes
Journal:  Mol Cell Biol       Date:  1993-09       Impact factor: 4.272

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.